Skip to content

Price / sales at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
2.9×+1.9×
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
8.1×-4.7×
Viatris logo
ViatrisVTRS
1.1×+0.3×
AMP
Amphastar PharmaceuticalsAMPH
1.2×-0.7×
AptarGroup logo
AptarGroupATR
2.1×-0.7×
AbbVie logo
AbbVieABBV
6.1×-0.3×

Other financials

Income statement

See full
Revenue$14.4M+65.7%
Gross profit$11.0M+117%
Operating income-$4.2M+78.3%
Net income-$8.1M+64.9%
EPS (diluted)-$0.07+70.8%

Balance sheet

See full
Cash & equivalents$110.7M+61.3%
Total debt$64.4M+7.4%
Total equity-$34.1M+44.1%
Total assets$141.1M+38.0%

Cash flow

See full
Operating cash flow-$14.8M+36.7%
CapEx$52.0K-61.5%
Free cash flow-$14.9M+36.9%

Valuation

See full
Market cap$560.13M+73.5%
Enterprise value$513.76M+63.6%

Profitability

See full
Gross margin63.5%-4.9pp
Operating margin-111.2%+96.3pp
Net margin-137.1%+80.7pp
FCF margin-88.2%-2.2pp

Returns & leverage

See full
Return on equity145.1%
Debt / equity-1.9×
Current ratio4.1×-0.8×

Where this comes from

Calculated from Aquestive Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aquestive Therapeutics, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aquestive Therapeutics, Inc.'s price / sales?
Aquestive Therapeutics, Inc. (AQST) reported price / sales of 10.1× in Q1 2026.
How has Aquestive Therapeutics, Inc.'s price / sales changed year-over-year?
Aquestive Therapeutics, Inc.'s price / sales increased by 90.5% year-over-year, from 5.3× to 10.1×.
What is the long-term trend for Aquestive Therapeutics, Inc.'s price / sales?
Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s price / sales has grown at a 30.4% compound annual growth rate (CAGR), from 4.7× to 17.7×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.